Coloplast Total Assets 2014-2019 | CLPBY

Coloplast total assets from 2014 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Coloplast total assets for the quarter ending March 31, 2019 were $1.871B, a 11.13% decline year-over-year.
  • Coloplast total assets for 2018 were $1.881B, a 5.03% increase from 2017.
  • Coloplast total assets for 2017 were $1.791B, a 9.11% increase from 2016.
  • Coloplast total assets for 2016 were $1.641B, a INF% increase from 2015.
Coloplast Annual Total Assets
(Millions of US $)
2018 $1,881
2017 $1,791
2016 $1,641
2015 $0
Coloplast Quarterly Total Assets
(Millions of US $)
Q2 2019 $1,871
Q1 2018 $1,853
Q4 2018 $1,881
Q3 2018 $2,028
Q2 2018 $2,105
Q1 2017 $1,925
Q4 2017 $1,791
Q3 2017 $1,811
Q2 2017 $1,794
Q1 2016 $1,867
Q4 2016 $1,641
Q1 2015 $0
Q3 2014 $0
Q2 2014 $0
Q1 2013 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.818B $2.629B
Coloplast A/S develops and provides health care products and services. Its operating business segments consist of Chronic Care, Urology Care and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Urology Care segment offers urological products, including disposable products. The Wound and Skin Care segment covers the sale of wound and skin care products. Coloplast A/S is headquartered in Humlebaek, Denmark.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.337B 20.26
Abbott Laboratories (ABT) United States $140.738B 26.45
Stryker (SYK) United States $79.987B 27.66
Boston Scientific (BSX) United States $53.253B 25.83
Baxter (BAX) United States $44.944B 27.25
EssilorLuxottica Societe Anonyme (ESLOY) France $32.375B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.93
Lonza Group Ag (LZAGY) Switzerland $24.634B 0.00
Terumo (TRUMY) Japan $23.332B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.543B 0.00
ResMed (RMD) United States $18.641B 35.52
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.871B 52.91
Insulet (PODD) United States $9.245B 547.82
Perrigo (PRGO) Ireland $7.271B 13.39
Canopy Growth (CGC) Canada $6.759B 0.00
Hill-Rom Holdings (HRC) United States $6.636B 19.78
Haemonetics (HAE) United States $6.525B 49.24
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Neogen (NEOG) United States $3.350B 56.05
NuVasive (NUVA) United States $3.316B 26.44
ICU Medical (ICUI) United States $3.170B 20.56
Quidel (QDEL) United States $2.389B 23.72
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.290B 0.00
Agios Pharmaceuticals (AGIO) United States $1.917B 0.00
National Vision Holdings (EYE) United States $1.879B 40.56
Cardiovascular Systems (CSII) United States $1.641B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.080B 24.88
AtriCure (ATRC) United States $1.009B 0.00
Phibro Animal Health (PAHC) United States $0.855B 13.90
Eagle Pharmaceuticals (EGRX) United States $0.821B 20.92
Omeros (OMER) United States $0.756B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Lantheus Holdings (LNTH) United States $0.737B 19.38
PetIQ (PETQ) United States $0.712B 16.81
Cerus (CERS) United States $0.630B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.86
Surmodics (SRDX) United States $0.573B 109.00
MacroGenics (MGNX) United States $0.556B 0.00
Quanterix (QTRX) United States $0.547B 0.00
TG Therapeutics (TGTX) United States $0.493B 0.00
OraSure Technologies (OSUR) United States $0.475B 22.00
Owens & Minor (OMI) United States $0.399B 11.94
Meridian Bioscience (VIVO) United States $0.382B 11.93
Zynex (ZYXI) United States $0.379B 40.31
Utah Medical Products (UTMD) United States $0.347B 25.45
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
BioLife Solutions (BLFS) United States $0.309B 95.06
United Health Products (UEEC) United States $0.245B 0.00
Bovie Medical (APYX) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.160B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.128B 9.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.085B 20.14
Nephros (NEPH) United States $0.071B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00